Sitemap

Nicole Dale

More Than Conjugation: ADC Manufacturing

Pharmatica image of an ADC manufacturing facility showing antibody-drug conjugate drug product production and pharmaceutical processing equipment.

ADC manufacturing is becoming more complex as payloads, conjugation, lyophilisation, containment, and scale-up reshape CMC strategy and commercial readiness.

Nicole Dale

Continuous Manufacturing of Biologics Is Ready to Scale

Pharmatica image of a stainless-steel bioreactor and connected equipment in a bright biopharmaceutical manufacturing facility, illustrating continuous biologics production.

Continuous manufacturing of biologics could cut facility costs by up to 50%. Learn what ICH Q13 and the latest evidence mean for pharma teams.

Nicole Dale

Inside the GMP Inspection Process, Explained

Pharmatica image of a pharmaceutical GMP inspection team reviewing manufacturing operations, quality records, and regulatory compliance in a modern facility.

We map the GMP inspection process end to end, showing what regulators check, who is responsible, and where compliance often breaks down.

Nicole Dale

Pharmacovigilance Trends Shaping Drug Safety Reporting in 2026

Pharmatica image of a pharmaceutical blister packs and medicine bottles arranged with clinical safety documentation, representing AI-assisted pharmacovigilance and adverse event monitoring.

We explore the pharmacovigilance trends shaping drug safety in 2026, from AI and real-world data to ICH E2D(R1), to reporting quality for MedSafety Week 2026.

Nicole Dale

AI Bioweapons Risk Grows as Agent Safeguards Fail

Pharmatica image showing an AI agent network integrated with molecular and pharmaceutical research elements to represent biosecurity and the AI bioweapons risk.

The AI bioweapons risk has entered a new, more worrying phase as Moonshot AI’s Kimi’s jailbreak exposes gaps in agent safeguards.

Nicole Dale

SynthID Bio: Watermarking AI-Designed Proteins

Pharmatica image of a photorealistic blue protein structure with a subtle yellow highlight representing AI-designed protein watermarking and biological provenance.

SynthID Bio embeds hidden watermarks in AI-designed proteins. See how Google DeepMind’s tool could strengthen biosecurity and what pharma R&D should do next.